Stocks
Sanofi (SNY) EBITDA US GAAP (year values) |
|||||||||
| 2021 | 2022 | 2022 | 2023 | 2023 | LTM ? | CAGR 5 years ? | |||
| EBITDA, € | ? | 11 538 000 000 | 14 062 000 000 | 14 303 000 000 | 12 959 000 000 | 12 604 000 000 | 8 697 500 000 | ||
| Changes by years, y/y, % | +7% | +22% | +2% | -9% | -3% | +2.4% | |||
Sanofi. EBITDA US GAAP, €
Sanofi. EBITDA US GAAP, changes, %
Sanofi. EBITDA US GAAP, sum by quarters, €
Sanofi (SNY) EBITDA US GAAP (quarter values) |
||||||||
| 2023Q4 | 2023Q4 | 2024Q1 | 2024Q1 | 2024Q2 | LTM ? | |||
| EBITDA, € | ? | 7 766 000 000 | 1 644 500 000 | 2 865 000 000 | 2 162 000 000 | 2 026 000 000 | 8 697 500 000 | |
| Changes by years, y/y, % | +161% | -45% | -15% | -36% | -18% | |||
| Changes by quarters, q/q, % | +98% | -79% | +74% | -25% | -6% | |||
